Advertisement
Screener

ORIC PHARMACEUTICALS, INC. (ORIC) Other

ORIC PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-23: Form 10-K; Item Smaller reporting company; As filed Yes.
  • 2025-11-13: Form 10-Q; Item Smaller reporting company; As filed Yes.
  • 2025-11-13: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2025-08-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
FiledFormItemAs filed
2026-02-2310-KSmaller reporting companyYes
2025-11-1310-QSmaller reporting companyYes
2025-11-1310-QEmerging growth companyYes
2025-08-1210-QSmaller reporting companyYes
2025-08-1210-QEmerging growth companyYes
2025-05-0510-QSmaller reporting companyYes
2025-05-0510-QEmerging growth companyYes
2025-02-1810-KSmaller reporting companyYes
2025-02-1810-KEmerging growth companyYes
2024-11-1210-QSmaller reporting companyYes
2024-11-1210-QEmerging growth companyYes
2024-08-1210-QSmaller reporting companyYes
2024-08-1210-QEmerging growth companyYes
2024-05-0610-QSmaller reporting companyYes
2024-05-0610-QEmerging growth companyYes
2024-03-1110-KSmaller reporting companyYes
2024-03-1110-KEmerging growth companyYes
2024-03-1110-KWell-known seasoned issuerNo
2023-11-0610-QSmaller reporting companyYes
2023-11-0610-QEmerging growth companyYes
2023-08-1010-QSmaller reporting companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-0810-QSmaller reporting companyYes
2023-05-0810-QEmerging growth companyYes
2023-03-1610-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2023-03-1610-KSmaller reporting companyYes
2023-03-1610-KEmerging growth companyYes
2023-03-1610-KWell-known seasoned issuerNo
2022-11-0710-QSmaller reporting companyYes
2022-11-0710-QEmerging growth companyYes
2022-08-1110-QSmaller reporting companyYes
2022-08-1110-QEmerging growth companyYes
2022-05-0910-QSmaller reporting companyYes
2022-05-0910-QEmerging growth companyYes
2022-03-2110-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2022-03-2110-KEmerging growth companyYes
2022-03-2110-KWell-known seasoned issuerNo
2021-11-0810-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · The NASDAQ Global Select Market
2021-11-0810-QEmerging growth companyYes
2021-08-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · The NASDAQ Global Select Market
2021-08-1010-QEmerging growth companyYes
2021-05-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2021-05-0610-QEmerging growth companyYes
2021-03-2310-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2021-03-2310-KEmerging growth companyYes
2021-03-2310-KWell-known seasoned issuerNo
2020-11-0510-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2020-11-0510-QEmerging growth companyYes
2020-08-0510-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2020-08-0510-QEmerging growth companyYes
2020-05-2010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ORIC · NASDAQ
2020-05-2010-QEmerging growth companyYes
2020-05-2010-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
OMEROS CORP (OMER)United States$1.456B5.50
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
Avalyn Pharma Inc. (AVLN)United States$1.267B
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62